Skip to contentWEISER MICHAEL — ZIOPHARM ONCOLOGY INC insider: 164 transactions · InsiderLensWEISER MICHAEL
- Director at Paramount Acquisition Corp · on record since Jan 30, 2006
- Executive Vice President at Paramount Acquisition Corp · on record since Jan 30, 2006
- Director at KANAI SCIENCES, INC. · on record since Jan 30, 2006
- President and Secretary at KANAI SCIENCES, INC. · on record since Jan 30, 2006
- Director at SEWARD SCIENCES, INC. · on record since Jan 30, 2006
- President and Secretary at SEWARD SCIENCES, INC. · on record since Jan 30, 2006
- Director at KODIAK SCIENCES, INC. · on record since Jan 30, 2006
- President and Secretary at KODIAK SCIENCES, INC. · on record since Jan 30, 2006
- Director at Chelsea Therapeutics International, Ltd. · on record since Jan 23, 2006
- Director at Hana Biosciences Inc · on record since Feb 10, 2006
- Director at MANHATTAN PHARMACEUTICALS INC · on record since Feb 2, 2006
- Director at EMISPHERE TECHNOLOGIES INC · on record since May 31, 2006
- Director at ZIOPHARM ONCOLOGY INC · on record since Apr 27, 2006
- Director at Innovive Pharmaceuticals, Inc. · on record since May 5, 2006
- Former Director at MANHATTAN PHARMACEUTICALS INC · on record since Mar 10, 2010
- Director at VioQuest Pharmaceuticals, Inc. · on record since Jul 13, 2007
- Former Dir., Pres & Sec (1) at KODIAK SCIENCES, INC. · on record since Mar 27, 2008
- Former Dir., Pres & Sec (1) at KANAI SCIENCES, INC. · on record since Mar 27, 2008
- FormerDirector,Pres and Sec(1) at SEWARD SCIENCES, INC. · on record since Mar 27, 2008
- Director at FREIGHT MANAGEMENT CORP · on record since Mar 19, 2018
- Director at IVORY CAPITAL CORP · on record since Feb 22, 2005
Insider trading activity of WEISER MICHAEL
- Transactions on record
- 164
- since Oct 30, 2003
- Open-market buys
- 16
- $105.1K
- Open-market sells
- 1
- $98K
- Companies traded
- 9
- last filing Jun 18, 2026
Figures computed from official regulatory filings — methodology.
Companies where WEISER MICHAEL has traded
- FREIGHT MANAGEMENT CORP13 tx · $68K · Jun 18, 2026
- ZIOPHARM ONCOLOGY INC43 tx · $961.2K · Jan 3, 2018
- EMISPHERE TECHNOLOGIES INC18 tx · May 24, 2017
- Chelsea Therapeutics International, Ltd.38 tx · $1.6M · Jun 25, 2014
- MANHATTAN PHARMACEUTICALS INC17 tx · $13.4K · Mar 10, 2010
- Hana Biosciences Inc14 tx · $16.3K · Feb 18, 2010
- VioQuest Pharmaceuticals, Inc.13 tx · $2.6M · Jun 18, 2008
- Innovive Pharmaceuticals, Inc.2 tx · Jul 13, 2006
- Paramount Acquisition Corp6 tx · $31K · Jan 30, 2006
Track record of WEISER MICHAEL
Statistical track record
Free- Open-market buys
- 24
- Last buy
- May 31, 2022
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of WEISER MICHAEL
Co-insiders of WEISER MICHAEL
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
MCINERNEY TIMOTHYEMISPHERE TECHNOLOGIES INC +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 18, 2026 | AwardD | 90,316 | 0.00 USD | — | SEC |
| Jun 17, 2025 | AwardD | 67,546 | 0.00 USD | $0 | SEC |
| Jun 13, 2024 | AwardD | 49,303 | 0.00 USD | $0 | SEC |
| Mar 5, 2024 | AwardD | 100,000 | 0.00 USD | $0 | SEC |
| Jun 8, 2023 | AwardD | 51,955 | 0.00 USD | $0 | SEC |
| Jun 14, 2022 | AwardD | 51,204 | 0.00 USD | $0 | SEC |
| Jun 2, 2022 | Buy | 2,187 | 6.79 USD | $14.8K | SEC |
| Jun 2, 2022 | Buy | 7,813 | 6.80 USD | $53.1K | SEC |
| Jul 1, 2021 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| Jun 10, 2020 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| Jun 11, 2019 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Jul 19, 2018 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| Mar 19, 2018 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Jan 3, 2018 | Award | 17,258 | 0.00 USD | $0 | SEC |
| Jan 3, 2018 | Other | -6,021 | 4.14 USD | $24.9K | SEC |
| Dec 11, 2017 | Exercise | 20,000 | 2.73 USD | $54.6K | SEC |
| Dec 11, 2017 | ExerciseD | -20,000 | 0.00 USD | $0 | SEC |
| Dec 11, 2017 | Other | -12,325 | 4.43 USD | $54.6K | SEC |
| Jun 14, 2017 | Other | -13,300 | 5.47 USD | $72.8K | SEC |
| Jun 14, 2017 | Exercise | 15,000 | 4.85 USD | $72.8K | SEC |
| Jun 14, 2017 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| May 24, 2017 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Jan 4, 2017 | Award | 17,204 | 0.00 USD | $0 | SEC |
| Jan 4, 2017 | Other | -9,331 | 5.35 USD | $49.9K | SEC |
| May 26, 2016 | AwardD | 40,000 | 0.00 USD | $0 | SEC |